Fundo DE Investimento Imobiliario - BRL Prop II (BRLA11) Cotización

https://abcnews.go.com/International/wireStory/japan-links-chinese-hacker-mirrorface-dozens-cyberattacks-targeting-117452466
They can trace them but by using Wave, they should stop them.

🏆️Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analytic, Inc.
30,000,000 Shares

Right. The little ego maniac wasn’t getting all the attention anymore boo hoo hoo. Everyone was dumping his hype and investing in the future. Quantum is here and now and and he knows it and is scared to death. He’s seen his investors like myself pull out in droves and make 400% other money instead o

HALO raises '25 guidance, and new 'accelerated' share repurchase

Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance
Jan. 08, 2025 7:00 AM ET Halozyme Therapeutics, Inc. (HALO)
Reports Preliminary 2024 Unaudited Estimated Ranges

To da moon any day!

.135 on 113M already, crazy ~Rig

Anyway the quantum computers are the future of the computers.

Fact or opinion?

Down a lot ..still worth grabbing???

Gshores Wrote the following back in May when the PPS was at its height:
someone is loading up at .0129, not sure if its MM's or shorts or big investor, but the wall is there for a reason, going to blow up soon imo. love this company!
Why anybody would take such a fool seriously is beyo

This will be pretty volitile for the next few months...

Until we see some revenue contracts that exceed testing money no one will be happy... 

Plus I figure we're 2 Q's away from being profitable... 

Exceptional company products and management 
Top

🇺🇸Hearing a MOASS takes $DJT to MARS!🇺🇸wow🇺🇸🇺🇸🇺🇸

As Dew stated :
Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jan 08, 2025

WATERTOWN, Mass.--(BUSINESS WIRE)--Jan. 8, 2025-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating

"We've dramatically strengthened our financial health, improving our shareholder equity from approximately -$7.164M to -$1.176M. This significant balance sheet cleanup, including the elimination of all outstanding convertible debt, provides a solid foundation for aggressive growth".

Vyvanse Quota going Fast.

I can't even think of a reason not to PR this data.

There are competitive reasons not to release details on these studies if your goal is to minimize copycats.

The new Chief Financial Officer, Daniel Gilcher, has already been discredited. The guy is peddling 2023 numbers while knowing the company's financials and stock has plummeting since. Their year over year revenue for the first half of 2024 was down 71%. Net profit down 434% with a negative EBITA per

What you takin about Williis

.121 bought the dip ~Rig

The PR could also be intended to facilitate a financing round.

Yes, Good point. FYI- Metsera is already pretty well funded. They already got an initial $350 million to start the company which they used partially to buy up some Korean compounds and attract some well known (very highly

Trend lines don't lie! Gonna be a Banger day with PR news please don't sell on news if it's positive like DUH... 😂🤦🏻‍♂️🤦🏻‍♂️🤦dz

>

I was being kind when I said that it was about 5-10 years away....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175443221

Trendline looks insane!!!! 

lol, you know I was being sarcastic.